Opioid-use disorder is a treatable medical condition.
Opioid-use disorder is a treatable medical condition.
Medication for Opioid Use Disorder combines FDA-approved medication with appropriate medical care, behavioral-health treatment, recovery support, and ongoing monitoring.
At Newport Integrated Behavioral Healthcare, treatment is individualized according to each patient's clinical needs, treatment goals, medical history, and recovery plan.
Medication choice is determined by the treating medical provider after evaluation of the patient's current opioid use, medical history, treatment goals, risks, benefits, and other clinical factors.
Buprenorphine is an evidence-based medication used in the treatment of opioid-use disorder.
It can reduce opioid withdrawal symptoms and cravings and help stabilize individuals so they can more fully participate in recovery and other areas of life.
The medical provider determines whether buprenorphine is clinically appropriate after evaluation.
Suboxone is a formulation containing buprenorphine and naloxone.
When clinically appropriate, it may be used as part of an individualized treatment plan for opioid-use disorder.
Patients receive ongoing medical follow-up and are encouraged to participate in behavioral-health and recovery-support services that address the broader needs associated with recovery.
Sublocade is an extended-release injectable form of buprenorphine administered at clinically appropriate intervals for eligible patients.
For some individuals, extended-release medication can help reduce the burden of daily medication administration while maintaining treatment for opioid-use disorder.
Eligibility is determined by the prescribing clinician.
Extended-release naltrexone is another medication option used in treatment of opioid-use disorder for clinically appropriate individuals.
Unlike buprenorphine, it is an opioid antagonist.
Patients must meet appropriate clinical requirements before initiation. The medical provider will discuss risks, benefits, alternatives, and whether this medication is appropriate.
Medication addresses important biological aspects of opioid-use disorder, but recovery may also involve psychological, relational, occupational, and social needs.
Many individuals with substance-use disorders also experience depression, anxiety, trauma-related symptoms, bipolar disorder, sleep problems, or other psychiatric conditions.
When indicated, Newport can integrate psychiatric evaluation and medication management with substance-use treatment so that co-occurring behavioral-health needs are addressed.
Peer recovery services help patients receive encouragement and practical recovery support from individuals who understand the recovery process.
Treatment recommendations are individualized. A Newport medical provider can answer questions specific to your clinical situation.
No. MOUD uses evidence-based medications under medical supervision to treat opioid-use disorder. The goal is to reduce withdrawal, cravings, overdose risk, and continued illicit opioid use while supporting long-term recovery.
Treatment recommendations are individualized. Counseling and recovery-support services are strongly encouraged because medication is most effective when the individual's broader recovery needs are also addressed.
There is no single treatment duration that is appropriate for everyone. Medication decisions are made between the patient and treating medical provider based on clinical stability, risks, benefits, recovery progress, and individual circumstances.
Medication initiation depends on clinical assessment, current opioid use, withdrawal status, medical history, medications, and the specific medication being considered.
A recurrence of opioid use should prompt reassessment—not abandonment of treatment. The treatment team will evaluate safety, medication adherence, triggers, level-of-care needs, and whether the recovery plan should be modified.
Yes. Naloxone remains an important overdose-prevention tool for individuals at risk of opioid overdose and their families/support systems.
Hospitals, emergency departments, physicians, behavioral-health providers, courts, community organizations, and other referral sources may contact Newport for MOUD screening and coordination.
Our “mission” is to provide integrated behavioral, psychiatric, and substance abuse services that are accessible, effective, safe, efficient, and appropriate to the needs of the consumers and his/her family.
Website Designed By G4 Design House
Copyright © 2026. All rights reserved.
